MODIFIED ACR COMPOSITE RESPONSE INDEX IN SYSTEMIC SCLEROSIS SCORE SHOWS SENSITIVITY AND EXTERNAL VALIDATION TO MEASURE MAGNITUDE OF RESPONSE AT 12 MONTHS IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS

被引：2
|
作者：
Abignano, Giuseppina [1 ,2 ,3 ]
Carriero, Antonio [1 ,3 ]
Eng, Sookhoe [1 ,2 ]
Del Galdo, Francesco [1 ,2 ]
机构：
[1] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England
[2] Leeds Teaching Hosp NHS Trust, NIHR Leeds Biomed Res Ctr, Leeds, W Yorkshire, England
[3] Rheumatol Inst Lucania IReL, Rheumatol Dept Lucania, Potenza, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
D O I：
10.1136/annrheumdis-2019-eular.7962
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0262
引用
收藏
页码：1207 / 1208
页数：2
相关论文
共 49 条
  • [31] Evaluation of American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis (CRISS) in the Fasscinate Trial
    Khanna, Dinesh
    Berrocal, Veronica J.
    Denton, Christopher
    Jahreis, Angelika
    Spotswood, Helen
    Lin, Celia J. F.
    Siegel, Jeffrey
    Furst, Daniel E.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [32] Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months
    Touma, Zahi
    Urowitz, Murray B.
    Taghavi-Zadeh, Shahrzad
    Ibanez, Dominique
    Gladman, Dafna D.
    RHEUMATOLOGY, 2012, 51 (10) : 1814 - 1819
  • [33] UVA1 for diffuse cutaneous systemic sclerosis in a Fitzpatrick skin type VI patient: outcomes in the modified Rodnan skin score
    Ferreira, B. R.
    Gameiro, A. R.
    Brites, M. M.
    Oliveira, H. S.
    Reis, J. P.
    ACTA REUMATOLOGICA PORTUGUESA, 2017, 42 (02): : 196 - 197
  • [34] Modified Rodnan Skin Score Thresholds for the Optimization of Cohort Enrichment in Clinical Trials in Skin Fibrosis in Patients with Diffuse Cutaneous Systemic Sclerosis
    Dobrota, Rucsandra
    Maurer, Britta
    Graf, Nicole
    Jordan, Suzana
    Mihai, Carmen Marina
    Kowal-Bielecka, Otylia
    Allanore, Yannick
    Distler, Oliver
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [35] Circulating levels of active transforming growth factor β1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score
    Dziadzio, M
    Smith, RE
    Abraham, DJ
    Black, CM
    Denton, CP
    RHEUMATOLOGY, 2005, 44 (12) : 1518 - 1524
  • [36] Correlation of the American College of Rheumatology Provisional Composite Response Index in Systemic Sclerosis with Serum Biomarkers of Fibrogenesis in an Observational Cohort
    Abignano, Giuseppina
    Eng, Sookhoe
    Buch, Maya H.
    Emery, Paul
    Khanna, Dinesh
    Del Galdo, Francesco
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [37] CORRELATION OF THE AMERICAN COLLEGE OF RHEUMATOLOGY PROVISIONAL COMPOSITE RESPONSE INDEX IN SYSTEMIC SCLEROSIS WITH SERUM BIOMARKERS OF FIBROGENESIS IN AN OBSERVATIONAL COHORT
    Abignano, Giuseppina
    Blagojevic, Jelena
    Eng, Sookhoe
    Buch, Maya
    Emery, Paul
    Khanna, Dinesh
    Del Galdo, Francesco
    RHEUMATOLOGY, 2018, 57
  • [38] RESULTS FROM A NOMINAL GROUP TECHNIQUE EXERCISE FOR THE CREATION OF A COMBINED RESPONSE INDEX FOR LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: THE CRISTAL PROJECT
    Lescoat, A.
    Chen, Y.
    Murphy, S. L.
    Carroll, L.
    Vann, N.
    Didio, P.
    Iya, S.
    Phanhdone, T.
    Farrington, S.
    Allanore, Y.
    Cella, D.
    Chung, L.
    Clements, P.
    Del Galdo, F.
    Denton, C. P.
    Distler, O.
    Hinchcliff, M.
    Hughes, M.
    Hummers, L.
    Pauling, J.
    Pope, J.
    Steen, V.
    Varga, J.
    Merkel
    Buch, M. H.
    Khanna, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 971 - 972
  • [39] Histologic Features Correlate with the Modified Rodnan Skin Score, Serum Inflammatory Markers, and Patient Reported Outcomes in Patients with Early, Diffuse Cutaneous Systemic Sclerosis
    Showalter, Kimberly
    Magro, Cynthia
    Orange, Dana
    Zhang, Yaxia
    Agius, Phaedra
    Finik, Jackie
    Spiera, Robert
    Gordon, Jessica
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [40] Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
    Chakravarty, Eliza F.
    Martyanov, Viktor
    Fiorentino, David
    Wood, Tammara A.
    Haddon, David James
    Jarrell, Justin Ansel
    Utz, Paul J.
    Genovese, Mark C.
    Whitfield, Michael L.
    Chung, Lorinda
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
12345